Literature DB >> 19836465

Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.

Helen H Wang1, Piero Portincasa, Min Liu, Patrick Tso, Linda C Samuelson, David Q-H Wang.   

Abstract

We investigated the effect of gallbladder hypomotility on cholesterol crystallization and growth during the early stage of gallstone formation in CCK knockout mice. Contrary to wild-type mice, fasting gallbladder volumes were enlarged and the response of gallbladder emptying to a high-fat meal was impaired in knockout mice on chow or the lithogenic diet. In the lithogenic state, large amounts of mucin gel and liquid crystals as well as arc-like and tubular crystals formed first, followed by rapid formation of classic parallelogram-shaped cholesterol monohydrate crystals in knockout mice. Furthermore, three patterns of crystal growth habits were observed: proportional enlargement, spiral dislocation growth, and twin crystal growth, all enlarging solid cholesterol crystals. At day 15 on the lithogenic diet, 75% of knockout mice formed gallstones. However, wild-type mice formed very little mucin gel, liquid, and solid crystals, and gallstones were not observed. We conclude that lack of CCK induces gallbladder hypomotility that prolongs the residence time of excess cholesterol in the gallbladder, leading to rapid crystallization and precipitation of solid cholesterol crystals. Moreover, during the early stage of gallstone formation, there are two pathways of liquid and polymorph anhydrous crystals evolving to monohydrate crystals and three modes for cholesterol crystal growth. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836465      PMCID: PMC2830894          DOI: 10.1016/j.bbalip.2009.10.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  54 in total

1.  Gallbladder disease in patients on long-term parenteral nutrition.

Authors:  J J Roslyn; H A Pitt; L L Mann; M E Ament; L DenBesten
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

2.  A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction.

Authors:  G T Everson; D Z Braverman; M L Johnson; F Kern
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

3.  Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile.

Authors:  P F Levy; B F Smith; J T LaMont
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

4.  Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones.

Authors:  S P Lee; J T LaMont; M C Carey
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  Quasi-elastic light-scattering studies of aqueous biliary lipid systems. Cholesterol solubilization and precipitation in model bile solutions.

Authors:  N A Mazer; M C Carey
Journal:  Biochemistry       Date:  1983-01-18       Impact factor: 3.162

6.  Cholesterol crystals and the formation of cholesterol gallstones.

Authors:  A Sedaghat; S M Grundy
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

7.  Intermittency of cholesterol crystals in duodenal bile from gallstone patients.

Authors:  J W Marks; G Bonorris
Journal:  Gastroenterology       Date:  1984-09       Impact factor: 22.682

8.  Detection of occult gallbladder disease by duodenal drainage collected endoscopically. A clinical and pathologic correlation.

Authors:  P W Susann; F Sheppard; A J Baloga
Journal:  Am Surg       Date:  1985-03       Impact factor: 0.688

9.  Increased risk of cholelithiasis with prolonged total parenteral nutrition.

Authors:  H A Pitt; W King; L L Mann; J J Roslyn; W E Berquist; M E Ament; L DenBesten
Journal:  Am J Surg       Date:  1983-01       Impact factor: 2.565

10.  Abnormal gallbladder emptying in a subgroup of patients with gallstones.

Authors:  I S Pomeranz; E A Shaffer
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

View more
  20 in total

1.  The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2016-01-12       Impact factor: 4.686

2.  Cd36 knockout mice are protected against lithogenic diet-induced gallstones.

Authors:  Yan Xie; Vincenza Cifarelli; Terri Pietka; Elizabeth P Newberry; Susan M Kennedy; Amin Khalifeh-Soltani; Robin Clugston; Kamran Atabai; Nada A Abumrad; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2017-06-20       Impact factor: 5.922

3.  Effects of sphincter of Oddi motility on the formation of cholesterol gallstones.

Authors:  Zhong-Hou Rong; Hong-Yuan Chen; Xin-Xing Wang; Zhi-Yi Wang; Guo-Zhe Xian; Bang-Zhen Ma; Cheng-Kun Qin; Zhen-Hai Zhang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

4.  Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.

Authors:  Ornella de Bari; Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  J Lipid Res       Date:  2015-07-07       Impact factor: 5.922

5.  Lipid transport in cholecystokinin knockout mice.

Authors:  Alexandra King; Qing Yang; Sarah Huesman; Therese Rider; Chunmin C Lo
Journal:  Physiol Behav       Date:  2015-07-11

Review 6.  Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.

Authors:  Helen H Wang; Min Liu; Xiaodan Li; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2017-03-08       Impact factor: 4.686

7.  Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

Authors:  B Lavoie; B Nausch; E A Zane; M R Leonard; O B Balemba; A C Bartoo; R Wilcox; M T Nelson; M C Carey; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

Review 8.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

9.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

10.  The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice.

Authors:  Ornella de Bari; Helen H Wang; Piero Portincasa; Min Liu; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.